Atractylenolide I – 5 mg

Brand:
Cayman
CAS:
73069-13-3
Storage:
-20
UN-No:
Non-Hazardous - /

Atractylenolide I is a sesquiterpene that has been found in the rhizomes of A. macrocephala and has diverse biological activities, including anti-inflammatory, anti-angiogenic, anti-tumor, and antidepressant properties.{39945,39946,39947,39948} It inhibits LPS-induced increases in TNF-α and nitric oxide (NO) production, as well as inducible nitric oxide synthase (iNOS) activity, in murine peritoneal macrophages (IC50s = 23.1, 41, and 67.3 μM, respectively).{39945} Atractylenolide I reduces pouch fluid weight, inflammatory cell count, granuloma weight, and vascular index (ID50s = 24.18, 19.46, 14.44, and 15.15 mg/kg, respectively) in a mouse air pouch granuloma model induced by Freund’s complete adjuvant (FCA).{39946} It also reduces the number of microvessels in the air pouch wall by 58.27% when administered at a dose of 20 mg/kg and reduces the blood levels of TNF-α, IL-1β, IL-6, VEGF, placenta growth factor (PlGF), and bFGF in a dose-dependent manner in a mouse model of FCA-induced granuloma. Atractylenolide I inhibits the growth of T-24, 5637, RT4, and 253J bladder cancer cells in vitro (IC50s = 12.8-63.7 μM) and reduces tumor growth in T-24 and 253J mouse xenograft models in a dose-dependent manner.{39947} In a mouse model of depression induced by chronic unpredictable mild stress, atractylenolide I reverses stress-induced decreases in hippocampal levels of serotonin (5-HT; Item No. 14332) and norepinephrine (Item No. 16673) and reduces immobility time in the forced swim and tail suspension tests in a dose-dependent manner, indicating antidepressant-like activity.{39948}  

 

Available on backorder

SKU: 25061 - 5 mg Category:

Description

A sesquiterpene with diverse biological activities; inhibits LPS-induced increases in TNF-α and NO production, as well as iNOS activity, in murine peritoneal macrophages (IC50s = 23.1, 41, and 67.3 μM, respectively); reduces pouch fluid weight, inflammatory cell count, granuloma weight, and vascular index (ID50s = 24.18, 19.46, 14.44, and 15.15 mg/kg, respectively) in a mouse air pouch granuloma model induced by FCA; reduces the number of microvessels in the air pouch wall by 58.27% at 20 mg/kg and reduces the blood levels of TNF-α, IL-1β, IL-6, VEGF, PlGF, and bFGF in a dose-dependent manner in a mouse model of FCA-induced granuloma; inhibits the growth of T-24, 5637, RT4, and 253J bladder cancer cells in vitro (IC50s = 12.8-63.7 μM); reduces tumor growth in T-24 and 253J mouse xenograft models in a dose-dependent manner; reverses stress-induced decreases in hippocampal levels of 5-HT and norepinephrine and reduces immobility time in the forced swim and tail suspension tests in a dose-dependent manner in a mouse model of depression induced by chronic unpredictable mild stress


Formal name: 4aS,5,6,7,8,8aS-hexahydro-3,8a-dimethyl-5-methylene-naphtho[2,3-b]furan-2(4H)-one

Synonyms:  AO-I|ATL-1

Molecular weight: 230.3

CAS: 73069-13-3

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Natural Products|Terpenes||Research Area|Cancer||Research Area|Immunology & Inflammation|Innate Immunity||Research Area|Neuroscience|Behavioral Neuroscience|Depression